{"name":"Celltrion Pharm, Inc.","slug":"celltrion-pharm-inc","ticker":"","exchange":"","domain":"celltrionpharm.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Pioglitazone + Alogliptin","genericName":"Pioglitazone + Alogliptin","slug":"pioglitazone-alogliptin","indication":"Type 2 diabetes mellitus","status":"marketed"}]}],"pipeline":[{"name":"Pioglitazone + Alogliptin","genericName":"Pioglitazone + Alogliptin","slug":"pioglitazone-alogliptin","phase":"marketed","mechanism":"Pioglitazone improves insulin sensitivity by activating PPAR-γ, while alogliptin inhibits DPP-4 to increase incretin levels, together reducing blood glucose in type 2 diabetes.","indications":["Type 2 diabetes mellitus"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQMzNDVktyTHZ0YlNuaGFRdXg3YjFVMC1ydnBxemEwODlibVJuLTNCQW5rYy1XVHRpUTdjUlY0M1IyUkZXQmJGeGh3Vm5IOVpUZmp6QjR5bUlmR09tLXc2MlJ0OGpra1FvSDUyUThDMjlGRXl3ZnE3TVUyVFEtcEE3R0E4b21vb1dHcmh1ZUNtVTVYekNJcTExclpJVm4tdw?oc=5","date":"2025-10-20","type":"patent","source":"Bloomberg Law News","summary":"Regeneron and Celltrion Settle Eylea Biosimilar Patent Fight - Bloomberg Law News","headline":"Regeneron and Celltrion Settle Eylea Biosimilar Patent Fight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNT2NBWURVVFhkSjdsa3g3eGZvR2NKX2hqSGpjYjF3OFNVYlBzWDFQTnlMeFh2TlJMdnZHOW9wVVBFWWk2RzVoNjE0Z3VZMkNJeTlIb3RLUlRCTnRQSkVTeHdfVEFPUUt6VWpxbkdYa0tkdUNwSzVkOERUMXZDXzR1ZVhSV3VxQk1Mb2JoLWJ6OGE1TW8zVGVoQVlJMmhxcC01ZHc?oc=5","date":"2025-10-06","type":"patent","source":"PharmaTimes","summary":"Hikma and Celltrion deepen alliance to boost biosimilar access in MENA - PharmaTimes","headline":"Hikma and Celltrion deepen alliance to boost biosimilar access in MENA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNNWt2UEd5VFcxZllWNi1ESlJLUWtCc2psZTVXc2V3YU9zdEl6UXRZc191RnFtc3o5V0pHSjd3cC0tZTMzWENpUHphQUxSSTVXQzRSS0JrT3NLRE5NTVd6cC1Lc2gwQVEyUVo5WWZDZm1adEIzMzBtaXJxMy1pTUVSdDJ2aEwwQzNvcGpCQ0NyVUFYTnM?oc=5","date":"2025-09-23","type":"deal","source":"Pharmaceutical Commerce","summary":"Celltrion to Acquire Eli Lilly’s $330M Production Plant - Pharmaceutical Commerce","headline":"Celltrion to Acquire Eli Lilly’s $330M Production Plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxOTEhVS245emJONG1sZVR5RUIxQjR1NWdGVWY0SnBFNklIYmF4RDAtT3c4TlFBbElCTGhQSHVfUE1nX2FKLVF2Szc1U0VSYlphOVU2M21GTG4xYldtUmFkUEZuWlZfZ0NFNk4wazRPWngtTTZVajEyZjFJdGI2b3BOY2pBamhsSzZOR29aRlljamhVdkdZeHBNcGZyME0zLVYxUnYzT0FhdW5EbmhlR214bnVYVG1aTGNjZ0RzYWVjYXZJazgwTFFkamdJRGZvbm5BSWp6RU1yQWk2NG5VdGgtYWh0eVJkdjktUllTV1dmSVdfZ25oY2pMTkstREUybWdZZGFWTE9FWHdaelZBOXBZ?oc=5","date":"2025-09-16","type":"pipeline","source":"Business Wire","summary":"Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business - Business Wire","headline":"Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Bus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9jRHpCOTRMdlRvckdsSjFWSVd6WFd2UzZmd1dNUF9LQXRxVXlmWmtWMXdvQkdYajVPal9pS3pMQ0gzZmh2RTRfdmM2Z3ZSNG81eWdNREVEWG15NVpRSjRvaWtwRFpva0dwOUtSSjI4Zkk2MjdIWUc2LXNRNA?oc=5","date":"2025-08-08","type":"deal","source":"KED Global","summary":"Celltrion in talks to buy Eli Lilly plant in US for $504 million - KED Global","headline":"Celltrion in talks to buy Eli Lilly plant in US for $504 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPN2J5S3VFYVdWVXBIRG90ekk4QmE1YkVCanBRUnQ1MzAtcnhmZ193ekp4S0RfWHFpZVlKb2I2Z3N1cFdsLUJIMUdGLTN6b3RuOTV6OTBLUnpVZ1hEWjV1TlkxczZBOURqeVJlLXFHbVdQS1AwOWctenNCSW1GbnVvTWhvSFo5RHlEZTJhQ2FnMjBVbS00Z2o0YUtMV0hrT2dYa0c4VElkSUZybmFpUmd2TjJsTlBHRDlnQ0FfbmV3ZWNsLTVSakE?oc=5","date":"2025-07-30","type":"pipeline","source":"Fierce Pharma","summary":"Celltrion closes in on US plant purchase, dubbing drug substance facility 'fundamental' to tariff mitigation - Fierce Pharma","headline":"Celltrion closes in on US plant purchase, dubbing drug substance facility 'fundamental' to tariff mitigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPVVlwWkpLY0FEbnJHeHJSbTdPRmFnSmhIdEVEelFBZHktMHlLeGFpLV8zVzktcE5QWElYNU5sMmVhN1lRVlprMDRBRXkyRXNuYU9nWWNiNjRtaXUwOWx1UThiY25zendaQjVJNy1SR2xzYjZ4M2tLVndMOGw5NWlwYVl5cEpjY0h1SEpxY1VUTHJWUmpJd0dQWWtnUzhpbWhXU2F3RXI3Vk9ManNmdk1OWWd3ak13Q1UyMmthQmhndUlGRnZkNnQ3STJvS2ExbUtvT3paSWh2NHpUazZWVEVlMg?oc=5","date":"2025-07-28","type":"deal","source":"Reuters","summary":"South Korea's Celltrion says tapped to buy US pharma factory to offset tariff risk - Reuters","headline":"South Korea's Celltrion says tapped to buy US pharma factory to offset tariff risk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQbEJiaWN5OWhGbXhyNEYzNGVKWmQ1U21oYlhPTDMzRVIzQklpYXA1a1VVZnI4d2NsVkRWMXJ1enRpbHNSQXpDaUZWOXJ4OFpHX0E4S3g4bHFqSERjMHZid2Q0TEdqVlBvbkE4bllkV3VzOHdoUnpwTW5oNHRucmQydmh0OXh3UmxQTHF6LUVpd3dYQ2NHdnV6NmoycWVjak5ScnJn?oc=5","date":"2025-05-13","type":"pipeline","source":"BioWorld News","summary":"Korea pharma stocks rally; Celltrion welcomes US drug pricing - BioWorld News","headline":"Korea pharma stocks rally; Celltrion welcomes US drug pricing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE9LRGhoQlJKMVVqUXFsY0R3QU41TC1UZ2VmelU5X0ZtaXdpa2dYX2VGREVyN0ozTmxuZGs0M2dTbGl5WTU5RWNYa3Rrc0tORzF5T0xLaGFR?oc=5","date":"2024-08-19","type":"pipeline","source":"The Korea Herald","summary":"Celltrion eyes top 5 drug maker by 2030 - The Korea Herald","headline":"Celltrion eyes top 5 drug maker by 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBoOENweEFIVmFCekNxYWlBV0ZUdmFDbkRQckR0NXJwc0VXeW5Td2tDSVFibTdra1hqNHdrQVhFQ19sVjU0ak9TY3BFSTY4WTNjODFOMHg5ZXkxYVZuOWRWeVlfQUpTV2o3djFFRVZB?oc=5","date":"2024-08-16","type":"deal","source":"KED Global","summary":"Celltrion scraps merger with Celltrion Pharm - KED Global","headline":"Celltrion scraps merger with Celltrion Pharm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8xRVBCRlpSS1hGQ0pSYU5RbjcyekVaOUJ3NVlTYXNYckwtMmZwMG5xYkI4V3RRa3hwSi0zVnhucEV5THhXb3YzUzVDbUVDdEdENUZOZXp5S0ZBOWtiVkhaT29qMDAyM0VONHUyNGdn0gFyQVVfeXFMTWxHeU5yd2JwbFV1b2xBdDczT3FJaDk1QUlZaU9naGdkT1paOEpaSFRPbHpCV1dXVl9FU29rQjJOckZVM0pKamJsckR2aUNDSUpxeGdoQ3hxbWtaV1AzQXlDeC1jSzNZT04tLXV3OGdueFV3?oc=5","date":"2024-01-19","type":"deal","source":"koreabiomed.com","summary":"Dongwha Pharm acquires 4 of Celltrion's over-the-counter products - koreabiomed.com","headline":"Dongwha Pharm acquires 4 of Celltrion's over-the-counter products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPM3pPNkI5T2d2OEl5TUlnN28yZmEzd2dJWEtDM1BUNW1ubHpvcnFCc18zaHlqcHpmWDJVeDFWcWtPZW1OZEdwXzJhRkdmcjJqeHdYbkhWREJUVzJrSWgxV3luLTZpVEowSlRUal9YWXgxMDI0ZWJGX1JHLUhPOTV4ZUVmWVIyNzVsVUZ5WnFkU1ZiOFVUdFNhQlBSN2Q4b2Y0MnpHT2owQzkybkFLR1lJZUJSbng1bU1vRVVpdWl4VQ?oc=5","date":"2023-08-22","type":"deal","source":"BioWorld News","summary":"Celltrion, Celltrion Healthcare merger kicks off, rolling three-into-one ‘big pharma’ - BioWorld News","headline":"Celltrion, Celltrion Healthcare merger kicks off, rolling three-into-one ‘big pharma’","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}